Stimulation of soluble guanylate cyclase by vericiguat reduces skeletal muscle atrophy of mice following chemotherapy

Stimulation of soluble guanylate cyclase by vericiguat reduces skeletal muscle atrophy of mice following chemotherapy

Background: The chemotherapeutic doxorubicin (DOX) promotes severe skeletal muscle atrophy, which induces skeletal muscle weakness and fatigue. Soluble guanylate cyclase (sGC) contributes to a variety of pathophysiological processes, but whether it is involved in DOX-induced skeletal muscle atrophy...

Full description

Bibliographic Details
Main Authors:	Bo-ang Hu, Yu-lin Li, Hai-tao Han, Bin Lu, Xu Jia, Lu Han, Wei-xuan Ma, Ping Zhu, Zhi-hao Wang, Wei Zhang, Ming Zhong, Lei Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Pharmacology
Subjects:	doxorubicin soluble guanylate cyclase skeletal muscle atrophy protein synthesis protein degradation vericiguat
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1112123/full

Similar Items

Vericiguat in Heart Failure: Characteristics, Scientific Evidence and Potential Clinical Applications
by: Francesca Vannuccini, et al.
Published: (2022-10-01)

Emerging concepts in heart failure management and treatment: focus on vericiguat
by: Edgardo Kaplinsky, et al.
Published: (2023-01-01)

Soluble guanylate cyclase stimulators for heart failure: a network meta-analysis and subgroup analyses of reduced and preserved ejection fraction
by: Mohamed T. Abuelazm, et al.
Published: (2024-01-01)

Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats without Altering Cerebral Blood Volume
by: Ellis Nelissen, et al.
Published: (2021-08-01)

Tetrahydrobiopterin protects soluble guanylate cyclase against oxidative inactivation
by: Schmidt Kurt, et al.
Published: (2013-06-01)

Decoding signaling mechanisms: unraveling the targets of guanylate cyclase agonists in cardiovascular and digestive diseases
by: Qinan Yin, et al.
Published: (2023-12-01)

Soluble Guanylyl Cyclase Activators—Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension
by: Grzegorz Grześk, et al.
Published: (2023-01-01)

Changes of Adenylate Cyclase and Guanylate Cyclase in the Frontal Cortex, Lenticula, Corpus Amygdaloideum, and Hippocampus in Morphine-dependent Rats
by: Shijun Hong, et al.
Published: (2016-01-01)

Guanylate cyclase 1 relies on rhodopsin for intracellular stability and ciliary trafficking
by: Jillian N Pearring, et al.
Published: (2015-11-01)

Vericiguat in Heart Failure with a Reduced Ejection Fraction: Patient Selection and Special Considerations
by: Kassis-George H, et al.
Published: (2022-03-01)

Modulation of soluble guanylate cyclase ameliorates pulmonary hypertension in a rat model of chronic thromboembolic pulmonary hypertension by stimulating angiogenesis
by: John Zagorski, et al.
Published: (2022-01-01)

Structural Perspectives on the Mechanism of Soluble Guanylate Cyclase Activation
by: Elizabeth C. Wittenborn, et al.
Published: (2021-05-01)

Structural basis of retinal membrane guanylate cyclase regulation by GCAP1 and RD3
by: James B. Ames
Published: (2022-09-01)

The Transition of Photoreceptor Guanylate Cyclase Type 1 to the Active State
by: Manisha Kumari Shahu, et al.
Published: (2022-04-01)

The efficacy and safety of soluble guanylate cyclase modulation in patients with heart failure: a comprehensive meta-analysis of randomized controlled trials
by: Mehmet Emin Arayici, et al.
Published: (2024-03-01)

Molecular Properties of Human Guanylate Cyclase-Activating Protein 3 (GCAP3) and Its Possible Association with Retinitis Pigmentosa
by: Anna Avesani, et al.
Published: (2022-03-01)

Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma.
by: Emmanuel S Buys, et al.
Published: (2014-05-01)

Regulation of Soluble Guanylate Cyclase by Matricellular Thrombospondins: Implications for Blood Flow
by: Natasha M Rogers, et al.
Published: (2014-04-01)

Alteration of the soluble guanylate cyclase system in coronary arteries of high cholesterol diet‐fed rabbits
by: Masashi Tawa, et al.
Published: (2021-08-01)

Hydrogen sulfide regulates the redox state of soluble guanylate cyclase in CSE-/- mice corpus cavernosum microcirculation
by: Miguel A. Olivencia, et al.
Published: (2023-08-01)

Retinal degeneration protein 3 controls membrane guanylate cyclase activities in brain tissue
by: Yaoyu Chen, et al.
Published: (2022-12-01)

Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts
by: Bianca Saveria Fioretto, et al.
Published: (2024-02-01)

Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase
by: Arpeeta Sharma, et al.
Published: (2023-07-01)

Soluble guanylate cyclase mediates the relaxation of healthy and inflamed bladder smooth muscle by aqueous nitric oxide
by: Patrik Aronsson, et al.
Published: (2023-09-01)

The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system
by: Susana S. Correia, et al.
Published: (2021-09-01)

Structural Insights into Retinal Guanylate Cyclase Activator Proteins (GCAPs)
by: James B. Ames
Published: (2021-08-01)

Effects of Soluble Guanylate Cyclase Stimulators and Activators on Anti-Aggregatory Signalling in Patients with Coronary Artery Spasm
by: Armin Muminovic, et al.
Published: (2023-05-01)

Dysfunction of outer segment guanylate cyclase caused by retinal disease related mutations
by: Patrick eZägel, et al.
Published: (2014-02-01)

Membrane Guanylate Cyclase catalytic Subdomain: Structure and Linkage with Calcium Sensors and Bicarbonate
by: Sarangan Ravichandran, et al.
Published: (2017-06-01)

Current Modulation of Guanylate Cyclase Pathway Activity—Mechanism and Clinical Implications
by: Grzegorz Grześk, et al.
Published: (2021-06-01)

Bibliometric study of soluble guanylate cyclase stimulators in cardiovascular research based on web of science from 1992 to 2021
by: Xiao-Yan Jia, et al.
Published: (2022-08-01)

A Signaling Factor Linked to Toxoplasma gondii Guanylate Cyclase Complex Controls Invasion and Egress during Acute and Chronic Infection
by: Shu Ye, et al.
Published: (2022-10-01)

Editorial: Multi-limbed membrane guanylate cyclase cellular signaling pathways
by: Rameshwar K. Sharma, et al.
Published: (2023-04-01)

The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases
by: Susana S. Correia, et al.
Published: (2021-05-01)

Multilimbed membrane guanylate cyclase signaling system, evolutionary ladder
by: Teresa Duda, et al.
Published: (2023-01-01)

Guanylate cyclase-C Signaling Axis as a theragnostic target in colorectal cancer: a systematic review of literature
by: Moein Piroozkhah, et al.
Published: (2023-10-01)

The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat
by: S. E. Gratsianskaya, et al.
Published: (2020-10-01)

Membrane Guanylate Cyclase, A Multimodal Transduction Machine: History, Present and Future Directions
by: Rameshwar K Sharma, et al.
Published: (2014-07-01)

ACTH-Modulated Membrane Guanylate Cyclase Signaling System: Origin and Creation
by: Rameshwar K. Sharma
Published: (2022-08-01)

Neurons exposed to ammonia reproduce the differential alteration in nitric oxide modulation of guanylate cyclase in the cerebellum and cortex of patients with liver cirrhosis
by: Regina Rodrigo, et al.
Published: (2005-06-01)